Treatment strategies for unresectable locally advanced non-small cell lung cancer in the real-life ESME cohort

•In a multicenter, nation-wide cohort of 8514 consecutive patients with advanced or metastatic lung cancer, 736 patients had unresectable locally advanced NSCLC.•OS rates at 24 months were similar -–55.3% and 53.2% respectively - for concurrent and sequential chemoradiotherapy.•Clinical outcomes wer...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Lung cancer (Amsterdam, Netherlands) Netherlands), 2021-12, Vol.162, p.119-127
Hauptverfasser:	Girard, Nicolas, Perol, Maurice, Simon, Gaëtane, Audigier Valette, Clarisse, Gervais, Radj, Debieuvre, Didier, Schott, Roland, Quantin, Xavier, Coudert, Bruno, Lena, Hervé, Carton, Matthieu, Robain, Mathieu, Filleron, Thomas, Chouaid, Christos
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Antineoplastic Combined Chemotherapy Protocols - therapeutic use Carcinoma, Non-Small-Cell Lung - drug therapy Carcinoma, Non-Small-Cell Lung - therapy Chemoradiotherapy Chemotherapy Cisplatin - therapeutic use Concurrent chemoradiotherapy Humans Locally advanced non-small cell lung cancer Lung Neoplasms - drug therapy Lung Neoplasms - therapy Male Observational cohort Radiotherapy Sequential chemoradiotherapy Unresectable non-small cell lung cancer
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!